Gainers
- Abiomed (NASDAQ:ABMD) shares increased by 50.3% to $378.91 during Tuesday's regular session. As of 13:30 EST, Abiomed's stock is trading at a volume of 5.0 million, which is 1802.3% of its average full-day volume over the last 100 days. The company's market cap stands at $17.2 billion. As per the news, the Q2 earnings report came out today.
- NantHealth (NASDAQ:NH) shares moved upwards by 32.3% to $0.43. As of 13:30 EST, NantHealth's stock is trading at a volume of 175.6K, which is 270.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $49.6 million.
- SAB Biotherapeutics (NASDAQ:SABS) stock rose 23.33% to $1.11. The market value of their outstanding shares is at $47.7 million.
- Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 21.12% to $2.34. As of 13:30 EST, Sonnet BioTherapeutics's stock is trading at a volume of 82.6 million, which is 4389.5% of its average full-day volume over the last 100 days. The company's market cap stands at $10.1 million.
- Aravive (NASDAQ:ARAV) shares moved upwards by 20.61% to $1.58. As of 13:30 EST, Aravive's stock is trading at a volume of 12.7 million, which is 5967.2% of its average full-day volume over the last 100 days. The company's market cap stands at $48.2 million.
- Erytech Pharma (NASDAQ:ERYP) shares increased by 17.44% to $0.74. The company's market cap stands at $22.9 million.
Losers
- Catalent (NYSE:CTLT) shares declined by 23.2% to $50.5 during Tuesday's regular session. As of 13:30 EST, Catalent's stock is trading at a volume of 7.1 million, which is 462.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.0 billion. As per the news, the Q1 earnings report came out today.
- Instil Bio (NASDAQ:TIL) shares declined by 22.13% to $2.57. Trading volume for this security as of 13:30 EST is 1.5 million, which is 384.3% of its average full-day volume over the last 100 days. The company's market cap stands at $333.3 million.
- Bone Biologics (NASDAQ:BBLG) stock fell 18.45% to $0.37. Trading volume for this security as of 13:30 EST is 644.2K, which is 347.2% of its average full-day volume over the last 100 days. The company's market cap stands at $5.1 million.
- PhaseBio Pharmaceuticals (NASDAQ:PHAS) shares decreased by 16.64% to $0.09. Trading volume for this security as of 13:30 EST is 20.3 million, which is 2055.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.2 million.
- Acorda Therapeutics (NASDAQ:ACOR) shares decreased by 15.85% to $0.9. The current volume of 9.9 million shares is 282.4% of Acorda Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $21.9 million. As per the news, the Q3 earnings report came out today.
- Myriad Genetics (NASDAQ:MYGN) stock fell 15.1% to $17.61. Trading volume for this security as of 13:30 EST is 549.3K, which is 111.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.4 billion. As per the news, the Q3 earnings report came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
